Senechio Gastro division was formed in 2015. It was carved out from Premiere division the oldest division of Senechio. Launched in 4 Southern states with a field force of 100 Professional Service Representative Gastro division was later was expanded to all India in 2015. Today, Senechio Gastro division operates with 285 Professional Services Representatives and a total of 363 field force including line managers.
Senechio Gastro division is ranked 5th in the Gastro-Intestinal therapy Covered market and 29th overall in IPM in the G.I. therapy market. Fourrts Gastro division’s Flagship brands Sucrafil & Sucrafil O ranked no. 1 in Sucralfate Therapy in India & across the world.
Purpose of the Division
According to WHO, more than 470 million or 39% of Indians suffer from gastrointestinal problems varying from heartburn to constipation and diarrhea. The purpose of Senechio gastro division is to bridge the therapy gaps in the management of Gastro-intestinal disorders by offering innovative path-breaking brands.
Major Therapeutic Categories
Senechio Gastro division is the only one in the Indian market to offer end to end solutions in GI therapy offering products from Mouth Ulcers to Piles.
Our Therapy offering in Gastroenterology includes
Luminal Gastroenterology: GERD, Reflux Esophagitis, Gastritis, Duodenal & gastric ulcers, Oral ulcers, Radiation Mucositis, Ulcerative colitis, Crohn’s disease, probiotic therapy for adults & children.
Hepato-Pancreato-Biliary diseases: NAFLD, Alcoholic Liver Disease, Viral Hepatitis, Cholestatic Liver Diseases (Gall stones, Cholangitis & Primary Biliary Cirrhosis), Drug-Induced Hepatitis, Pancreatic Insufficiency
Functional GI disorders: Functional Dyspepsia, IBS & Functional constipation
Colorectal diseases: Piles, Fissures, Solitary rectal ulcers & Radiation Proctitis